Welcome to our dedicated page for SmartKem SEC filings (Ticker: SMTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SmartKem, Inc. filings document the public-company record for an organic semiconductor technology developer with common stock listed on Nasdaq under SMTK. The filings cover material-event reports, Securities Act registration statements, notices about annual-report timing, and disclosures tied to its advanced-materials and transistor-backplane business.
Recent regulatory documents address material definitive agreements, convertible notes, preferred stock financings, warrants, private placements, resale registration matters, Nasdaq listing-compliance disclosures, officer and subsidiary governance changes, shareholder voting matters, operating and financial results, and capital-structure updates involving common stock, preferred stock, and warrant securities.
SmartKem, Inc. reported unregistered equity issuances and a potential strategic transaction. The company agreed to issue up to 500,000 shares of common stock to two consulting firms for investor relations services under an exemption from registration. It also previously issued 10,000 shares on each of July 1, August 1, and September 2, 2025 to vendors as payment for consulting work, also relying on a registration exemption.
The company signed a non-binding letter of intent with Jericho Energy Ventures Inc. for an all-stock business combination in which Jericho stockholders would own 65% and current SmartKem stockholders 35% of the fully diluted equity of the combined company. SmartKem would remain the Nasdaq-listed surviving entity, with Jericho’s chief executive officer leading the combined company and Jericho designating a majority of the board, subject to regulatory requirements. The LOI includes a 60-day exclusivity period and contemplates SmartKem purchasing Jericho common shares from treasury in an amount tied to regaining Nasdaq stockholders’ equity compliance or raising at least $5,000,000, with purchase amounts between $500,000 and $1,000,000. The parties emphasize there is no assurance a definitive agreement or closing will occur due to multiple financing, approval, and diligence conditions.
SmartKem, Inc. (SMTK) director Joseph Christopher Lizzio reported a sale of 150,000 shares on 09/10/2025 coded as a G transaction (price reported as $0), leaving him with 419,000 shares beneficially owned. The Form 4 was signed 09/25/2025 and indicates the filing is by one reporting person. No derivative transactions or additional details are disclosed in this filing.
SmartKem, Inc. (SMTK) director Joseph Christopher Lizzio filed an Initial Statement of Beneficial Ownership reporting direct ownership of 569,000 shares of common stock. The event requiring the statement is dated 09/08/2025, and the form is signed on 09/25/2025. The filing is a Form 3 (initial disclosure) indicating the reporting person is a director and the form was filed by one reporting person.
Joseph Christopher Lizzio reported beneficial ownership of 419,000 shares of SmartKem, Inc. common stock, representing 7.65% of the outstanding shares as of September 4, 2025. This total includes 180,000 shares held jointly with his spouse; the filing states he does not exercise voting or dispositive power over shares held by his adult children. The percentages are calculated using 5,479,787 shares outstanding based on the issuers SEC filing dated September 5, 2025. The Schedule 13G indicates the holdings were not acquired to influence control of the issuer, and the filing is signed and certified by Mr. Lizzio on September 24, 2025.
Insider option grant reported for SmartKem, Inc. (SMTK). Director Melisa Denis was granted a stock option to buy 22,466 shares of common stock at an exercise price of $1.16 per share, with a transaction date of 09/03/2025 and an expiration date of 09/03/2035. The option vests 25% on the grant date and the remaining shares vest in equal monthly installments over 36 months beginning 09/03/2025. The reporting was filed on 09/05/2025 and signed by an attorney-in-fact.
SmartKem, Inc. director Klaas de Boer was granted a stock option on 09/03/2025 for 22,466 shares with an exercise price of $1.16. The option vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months commencing on 09/03/2025. The option appears to expire on 09/03/2035. The Form 4 was filed by an attorney-in-fact, Ian Jenks, on 09/05/2025. The reporting person is identified as a director and the filing is made by one reporting person.
SmartKem, Inc. (SMTK) Form 4 shows Ian Jenks, Chairman & CEO and Director, was granted a stock option on 09/03/2025 to acquire 160,005 shares of Common Stock at an exercise price of $1.16 per share. The option vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months beginning September 3, 2025. The option is exercisable through 09/03/2035. The Form 4 was signed by Ian Jenks on 09/05/2025.
Insider grant and holdings summary: SmartKem CFO Barbra Keck was granted a stock option on 09/03/2025 giving the right to buy 71,077 shares of common stock at an exercise price of $1.16 per share. The option is exercisable through 09/03/2035. Following the grant, Keck beneficially owns 71,077 underlying shares, held directly. The option vests 25% at grant with the remainder vesting in equal monthly installments over 36 months beginning 09/03/2025, with monthly vesting on the 3rd.
Peruvemba Sriram Krishnamurthy, a director of SmartKem, Inc. (SMTK), was granted a stock option on 09/03/2025 for the right to buy 22,466 shares of Common Stock at an exercise price of $1.16 per share. The option was acquired and is exercisable under a schedule that vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months beginning September 3, 2025. The option expires on September 3, 2035. Following the reported transaction the reporting person directly beneficially owns 22,466 option shares. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/05/2025.
SmartKem, Inc. reported new equity awards and a change to its CEO’s employment terms. On September 3, 2025, the board’s Compensation Committee granted stock options at an exercise price of $1.16 per share to the CEO, CFO and four non-employee directors, vesting 25% immediately and the rest monthly over 36 months from October 3, 2025.
The company also amended CEO Ian Jenks’s employment agreement, increasing his cash severance from six to twelve months of base salary if he is terminated without Cause or resigns for Good Reason. As of September 5, 2025, SmartKem had 5,479,787 common shares outstanding.